Status:
RECRUITING
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Lead Sponsor:
Sun Yat-sen University
Conditions:
Multi-omics Technique
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-70 years
Brief Summary
The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy ...
Eligibility Criteria
Inclusion
- Recurrent or metastatic nasopharyngeal carcinoma patients
- All genders，range from 18～70 years old
- ECOG score 0 \~ 1
- Inform consent form
Exclusion
- Have or are suffering from other malignant tumors;
- Participating in other clinical trials;
- Drug or alcohol addition;
- Do not have full capacity for civil acts;
- Mental disorder;
- Pregnancy or lactation;
- Severe complication, eg, uncontrolled hypertension.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06197776
Start Date
July 15 2024
End Date
December 30 2026
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, China